| Literature DB >> 17164656 |
Isabelle Pellier1, Bertrand Leboucher, Petronela Rachieru, Norbert Ifrah, Xavier Rialland.
Abstract
High dose of cytosine arabinoside is usually used in treatment of acute myelogenous leukemia. Here we report 1 case of a child who developed neurologic toxicity and rapidly improved after flushing out of cerebral spinal fluid, suggesting it could be treatment in the acute phase of toxicity. Efficacy of this treatment could be explained by reducing cytosine arabinoside metabolites in central nervous system.Entities:
Mesh:
Substances:
Year: 2006 PMID: 17164656 DOI: 10.1097/MPH.0b013e31802d3e2d
Source DB: PubMed Journal: J Pediatr Hematol Oncol ISSN: 1077-4114 Impact factor: 1.289